# Mobidrop

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mobidrop

- Industry: Biotechnology
- Headquarters: Jiaxing, China
- Website: www.mobidrop.com
- Total disclosed funding: $38M
- Latest round: Series A (Jul 25, 2022)
- Investors on record: 6

## About

Established in 2018 and based in Jiaxing, China, Mobidrop is a biotech company that focuses on building a platform for molecular diagnostics and life science research. The company headquartered in Jiaxing, Zhejiang, with a Global Innovation and Business Center in Boston, has over 4,000 square meters of office space, laboratories and plants, including a P2 cell laboratory, a PCR amplification laboratory and a 100,000 square meter GMP manufacturing plant. Since its establishment, the company has owned more than 30 independent intellectual property rights, including 15 exclusive patents granted by Harvard University. In 2019, the company's single-cell sequencing method passed the test. In 2020, the company released the first generation of digital PCR all-in-one machine. The company has a P2 cell laboratory and a PCR amplification laboratory, etc. In November 2023, it raised pre-series B funding from new investor Zhejiang Venture Capital.

The company engages in the development of platform for molecular diagnostics and life science research. Its main products include single-cell sequencing platforms and digital PCR platforms. The single-cell sequencing platform adopts single-cell identification with f molecular tags, which enables stable cell separation during droplet generation. The company's products are used in medical and scientific research industries. At this stage, the company has launched its core product, MobiNova®-100 high-throughput single-cell transcriptome solution, including MobiNova®-100 single-cell sequencing library construction system, MobiCube® single-cell transcriptome library reagents and chips, and MobiVision® biomic analysis software.

## Funding rounds

- Series A, Jul 25, 2022, $15M — Source Code Capital, LYFE Capital, CS-CLOUD
- Series A, Aug 24, 2021, $23M — Huagai Capital, Source Code Capital, Proxima Ventures
- Angel, Nov 29, 2019 — Taiyou Fund

## Investors

- Taiyou Fund — Angel
- Huagai Capital (https://capitalatlas.ai/funds/huagai-capital) — Series A
- Source Code Capital (https://capitalatlas.ai/funds/source-code-capital) — Series A
- Proxima Ventures (https://capitalatlas.ai/funds/proxima-ventures) — Series A
- LYFE Capital — Series A
- CS-CLOUD — Series A